Global Immuno-Oncology Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 106

Report ID: 3951

Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
In 2018, the global Immuno-Oncology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Immuno-Oncology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immuno-Oncology development in United States, Europe and China.

The key players covered in this study
Amgen, Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie
Pfizer Inc.
Sanofi S.A.
EMD Serono
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte

Market segment by Type, the product can be split into
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy

Market segment by Application, split into
Hospitals
Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Immuno-Oncology status, future forecast, growth opportunity, key market and key players.
To present the Immuno-Oncology development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Immuno-Oncology are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Immuno-Oncology Market Size Growth Rate by Type (2014-2025)
1.4.2 Immune Checkpoint Inhibitors
1.4.3 Monoclonal Antibodies
1.4.4 Cytokine-Based Immunotherapy
1.4.5 Cancer Vaccines
1.4.6 CAR-T Cell Therapy
1.5 Market by Application
1.5.1 Global Immuno-Oncology Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Immuno-Oncology Market Size
2.2 Immuno-Oncology Growth Trends by Regions
2.2.1 Immuno-Oncology Market Size by Regions (2014-2025)
2.2.2 Immuno-Oncology Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Immuno-Oncology Market Size by Manufacturers
3.1.1 Global Immuno-Oncology Revenue by Manufacturers (2014-2019)
3.1.2 Global Immuno-Oncology Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI)
3.2 Immuno-Oncology Key Players Head office and Area Served
3.3 Key Players Immuno-Oncology Product/Solution/Service
3.4 Date of Enter into Immuno-Oncology Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Immuno-Oncology Market Size by Type (2014-2019)
4.2 Global Immuno-Oncology Market Size by Application (2014-2019)

5 United States
5.1 United States Immuno-Oncology Market Size (2014-2019)
5.2 Immuno-Oncology Key Players in United States
5.3 United States Immuno-Oncology Market Size by Type
5.4 United States Immuno-Oncology Market Size by Application

6 Europe
6.1 Europe Immuno-Oncology Market Size (2014-2019)
6.2 Immuno-Oncology Key Players in Europe
6.3 Europe Immuno-Oncology Market Size by Type
6.4 Europe Immuno-Oncology Market Size by Application

7 China
7.1 China Immuno-Oncology Market Size (2014-2019)
7.2 Immuno-Oncology Key Players in China
7.3 China Immuno-Oncology Market Size by Type
7.4 China Immuno-Oncology Market Size by Application

8 Japan
8.1 Japan Immuno-Oncology Market Size (2014-2019)
8.2 Immuno-Oncology Key Players in Japan
8.3 Japan Immuno-Oncology Market Size by Type
8.4 Japan Immuno-Oncology Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Immuno-Oncology Market Size (2014-2019)
9.2 Immuno-Oncology Key Players in Southeast Asia
9.3 Southeast Asia Immuno-Oncology Market Size by Type
9.4 Southeast Asia Immuno-Oncology Market Size by Application

10 India
10.1 India Immuno-Oncology Market Size (2014-2019)
10.2 Immuno-Oncology Key Players in India
10.3 India Immuno-Oncology Market Size by Type
10.4 India Immuno-Oncology Market Size by Application

11 Central & South America
11.1 Central & South America Immuno-Oncology Market Size (2014-2019)
11.2 Immuno-Oncology Key Players in Central & South America
11.3 Central & South America Immuno-Oncology Market Size by Type
11.4 Central & South America Immuno-Oncology Market Size by Application

12 International Players Profiles
12.1 Amgen, Inc
12.1.1 Amgen, Inc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Immuno-Oncology Introduction
12.1.4 Amgen, Inc Revenue in Immuno-Oncology Business (2014-2019)
12.1.5 Amgen, Inc Recent Development
12.2 AstraZeneca, Plc
12.2.1 AstraZeneca, Plc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Immuno-Oncology Introduction
12.2.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2014-2019)
12.2.5 AstraZeneca, Plc Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Immuno-Oncology Introduction
12.3.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Celgene Corporation
12.4.1 Celgene Corporation Company Details
12.4.2 Company Description and Business Overview
12.4.3 Immuno-Oncology Introduction
12.4.4 Celgene Corporation Revenue in Immuno-Oncology Business (2014-2019)
12.4.5 Celgene Corporation Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Immuno-Oncology Introduction
12.5.4 Eli Lilly and Company Revenue in Immuno-Oncology Business (2014-2019)
12.5.5 Eli Lilly and Company Recent Development
12.6 Merck & Co.
12.6.1 Merck & Co. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Immuno-Oncology Introduction
12.6.4 Merck & Co. Revenue in Immuno-Oncology Business (2014-2019)
12.6.5 Merck & Co. Recent Development
12.7 Hoffmann-La Roche AG
12.7.1 Hoffmann-La Roche AG Company Details
12.7.2 Company Description and Business Overview
12.7.3 Immuno-Oncology Introduction
12.7.4 Hoffmann-La Roche AG Revenue in Immuno-Oncology Business (2014-2019)
12.7.5 Hoffmann-La Roche AG Recent Development
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson Company Details
12.8.2 Company Description and Business Overview
12.8.3 Immuno-Oncology Introduction
12.8.4 Johnson & Johnson Revenue in Immuno-Oncology Business (2014-2019)
12.8.5 Johnson & Johnson Recent Development
12.9 Novartis International AG
12.9.1 Novartis International AG Company Details
12.9.2 Company Description and Business Overview
12.9.3 Immuno-Oncology Introduction
12.9.4 Novartis International AG Revenue in Immuno-Oncology Business (2014-2019)
12.9.5 Novartis International AG Recent Development
12.10 AbbVie
12.10.1 AbbVie Company Details
12.10.2 Company Description and Business Overview
12.10.3 Immuno-Oncology Introduction
12.10.4 AbbVie Revenue in Immuno-Oncology Business (2014-2019)
12.10.5 AbbVie Recent Development
12.11 Pfizer Inc.
12.12 Sanofi S.A.
12.13 EMD Serono
12.14 Gilead Sciences Inc.
12.15 Prometheus Therapeutics & Diagnostics
12.16 Aduro BioTech
12.17 Galena Biopharma
12.18 Bavarian Nordic
12.19 Celldex Therapeutics
12.20 ImmunoCellular Therapeutics
12.21 Incyte

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details